Stay updated with breaking news from Karyn oneil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Penn's gene therapy layoffs are the latest in biotech belt-tightening in Philly and beyond inquirer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.com Daily Mail and Mail on Sunday newspapers.
Top Spots to Live 2021: South of Boston - The Boston Globe bostonglobe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonglobe.com Daily Mail and Mail on Sunday newspapers.
Aro Biotherapeutics, a Philadelphia, PA-based biotechnology company pioneering the development of tissue-targeted genetic medicines, closed an $88m Series A financing. The round was led by Northpond Ventures and Cowen Healthcare Investments, with participation from HealthCap, BVF Partners L.P., and Ridgeback Capital. Existing investors, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), BioMotiv, LLC, and Ionis Pharmaceuticals, Inc. In conjunction with the funding, Shaan Gandhi, M.D., D.Phil., director at Northpond Ventures, joined Aro’s board of directors, along with Kevin Raidy, managing partner of Cowen Healthcare Investments. The company intends to use the funds to advance its lead therapeutic candidates into clinical development, with an initial focus in rare genetic and immune disorders. ....